Ian Barr - Publications

2007-2012 Chemistry University of California, Los Angeles, Los Angeles, CA 
 2013-2017 Chemistry University of California, Berkeley, Berkeley, CA 
 2017- Chemistry Dominican University of California 

68 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Martins AM, Latham JA, Martel PJ, Barr I, Iavarone AT, Klinman JP. A two-component protease in with high activity toward the peptide precursor of the redox cofactor pyrroloquinoline quinone. The Journal of Biological Chemistry. PMID 31427437 DOI: 10.1074/Jbc.Ra119.009684  0.6
2018 Barr I, Stich TA, Gizzi AS, Grove TL, Bonanno JB, Latham JA, Chung T, Wilmot CM, Britt RD, Almo SC, Klinman JP. X-ray and EPR Characterization of the Auxiliary Fe-S Clusters in the Radical SAM Enzyme PqqE. Biochemistry. PMID 29405700 DOI: 10.1021/Acs.Biochem.7B01097  0.6
2017 Latham JA, Barr I, Klinman JP. At the confluence of ribosomally synthesized peptide modification and radical S-adenosylmethionine (SAM) enzymology. The Journal of Biological Chemistry. PMID 28830931 DOI: 10.1074/Jbc.R117.797399  0.6
2016 Hines JP, Smith AT, Jacob JP, Lukat-Rodgers GS, Barr I, Rodgers KR, Guo F, Burstyn JN. CO and NO bind to Fe(II) DiGeorge critical region 8 heme but do not restore primary microRNA processing activity. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. PMID 27766492 DOI: 10.1007/S00775-016-1398-Z  1
2016 Jelley L, Levy A, Deng YM, Spirason N, Lang J, Buettner I, Druce J, Blyth C, Effler P, Smith D, Barr IG. Influenza C infections in Western Australia and Victoria from 2008-14. Influenza and Other Respiratory Viruses. PMID 27373693 DOI: 10.1111/irv.12402  1
2016 Gordon DL, Sajkov D, Honda-Okubo Y, Wilks SH, Aban M, Barr IG, Petrovsky N. Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant. Vaccine. PMID 27342914 DOI: 10.1016/j.vaccine.2016.05.071  1
2016 Ana-Sosa-Batiz F, Vanderven H, Jegaskanda S, Johnston A, Rockman S, Laurie K, Barr I, Reading P, Lichtfuss M, Kent SJ. Influenza-Specific Antibody-Dependent Phagocytosis. Plos One. 11: e0154461. PMID 27124730 DOI: 10.1371/journal.pone.0154461  1
2016 Barr I, Latham JA, Iavarone AT, Chantarojsiri T, Hwang JD, Klinman JP. The pyrroloquinoline quinone (PQQ) biosynthetic pathway: Demonstration of de novo carbon-carbon cross-linking within the peptide substrate (PqqA) in the presence of the Radical SAM enzyme (PqqE) and its peptide chaperone (PqqD). The Journal of Biological Chemistry. PMID 26961875 DOI: 10.1074/Jbc.C115.699918  0.6
2016 Barr IG, Vijaykrishna D, Sullivan SG. Differential age susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian influenza season. Euro Surveillance : Bulletin EuropéEn Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 21. PMID 26848118 DOI: 10.2807/1560-7917.Es.2016.21.4.30118  1
2015 Barr I, Guo F. Pyridine Hemochromagen Assay for Determining the Concentration of Heme in Purified Protein Solutions. Bio-Protocol. 5. PMID 27390766 DOI: 10.21769/BIOPROTOC.1594  1
2015 Milne GJ, Halder N, Kelso JK, Barr IG, Moyes J, Kahn K, Twine R, Cohen C. Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study. Influenza and Other Respiratory Viruses. PMID 26663701 DOI: 10.1111/irv.12367  1
2015 Ren B, McKinstry WJ, Pham T, Newman J, Layton DS, Bean AG, Chen Z, Laurie KL, Borg K, Barr IG, Adams TE. Structural and functional characterisation of ferret interleukin-2. Developmental and Comparative Immunology. PMID 26472619 DOI: 10.1016/j.dci.2015.10.007  1
2015 Cao P, Yan AW, Heffernan JM, Petrie S, Moss RG, Carolan LA, Guarnaccia TA, Kelso A, Barr IG, McVernon J, Laurie KL, McCaw JM. Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies. Plos Computational Biology. 11: e1004334. PMID 26284917 DOI: 10.1371/journal.pcbi.1004334  1
2015 Patterson Ross Z, Komadina N, Deng YM, Spirason N, Kelly HA, Sullivan SG, Barr IG, Holmes EC. Inter-Seasonal Influenza is Characterized by Extended Virus Transmission and Persistence. Plos Pathogens. 11: e1004991. PMID 26107631 DOI: 10.1371/Journal.Ppat.1004991  1
2015 Barr I, Weitz SH, Atkin T, Hsu P, Karayiorgou M, Gogos JA, Weiss S, Guo F. Cobalt(III) Protoporphyrin Activates the DGCR8 Protein and Can Compensate microRNA Processing Deficiency. Chemistry & Biology. 22: 793-802. PMID 26091172 DOI: 10.1016/J.Chembiol.2015.05.015  1
2015 Deng YM, Spirason N, Iannello P, Jelley L, Lau H, Barr IG. A simplified Sanger sequencing method for full genome sequencing of multiple subtypes of human influenza A viruses. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 68: 43-8. PMID 26071334 DOI: 10.1016/j.jcv.2015.04.019  1
2015 Bedford T, Riley S, Barr IG, Broor S, Chadha M, Cox NJ, Daniels RS, Gunasekaran CP, Hurt AC, Kelso A, Klimov A, Lewis NS, Li X, McCauley JW, Odagiri T, et al. Global circulation patterns of seasonal influenza viruses vary with antigenic drift. Nature. 523: 217-20. PMID 26053121 DOI: 10.1038/Nature14460  1
2015 Laurie KL, Guarnaccia TA, Carolan LA, Yan AW, Aban M, Petrie S, Cao P, Heffernan JM, McVernon J, Mosse J, Kelso A, McCaw JM, Barr IG. Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model. The Journal of Infectious Diseases. PMID 25943206 DOI: 10.1093/infdis/jiv260  1
2015 Latham JA, Iavarone AT, Barr I, Juthani PV, Klinman JP. PqqD is a novel peptide chaperone that forms a ternary complex with the radical S-adenosylmethionine protein PqqE in the pyrroloquinoline quinone biosynthetic pathway. The Journal of Biological Chemistry. 290: 12908-18. PMID 25817994 DOI: 10.1074/Jbc.M115.646521  0.6
2015 Barr IG, Kelly HA. Oseltamivir reduces clinical illness in households in Bangladesh The Lancet Infectious Diseases. 15: 617-619. PMID 25788163 DOI: 10.1016/S1473-3099(15)70084-8  1
2015 Chen-Yu Hsu A, Starkey MR, Hanish I, Parsons K, Haw TJ, Howland LJ, Barr I, Mahony JB, Foster PS, Knight DA, Wark PA, Hansbro PM. Targeting PI3K-p110α Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 191: 1012-23. PMID 25751541 DOI: 10.1164/rccm.201501-0188OC  1
2015 Vijaykrishna D, Holmes EC, Joseph U, Fourment M, Su YC, Halpin R, Lee RT, Deng YM, Gunalan V, Lin X, Stockwell TB, Fedorova NB, Zhou B, Spirason N, Kühnert D, ... ... Barr IG, et al. The contrasting phylodynamics of human influenza B viruses. Elife. 4: e05055. PMID 25594904 DOI: 10.7554/Elife.05055  1
2015 Fox A, Mai le Q, Thanh le T, Wolbers M, Le Khanh Hang N, Thai PQ, Thi Thu Yen N, Minh Hoa le N, Bryant JE, Duong TN, Thoang DD, Barr IG, Wertheim H, Farrar J, Hien NT, et al. Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection. The Journal of Infection. 70: 187-96. PMID 25224643 DOI: 10.1016/J.Jinf.2014.09.003  1
2015 Su YCF, Bahl J, Joseph U, Butt KM, Peck HA, Koay ESC, Oon LLE, Barr IG, Vijaykrishna D, Smith GJD. Phylodynamics of H1N1/2009 influenza reveals the transition from host adaptation to immune-driven selection Nature Communications. 6. DOI: 10.1038/ncomms8952  1
2014 Schultz-Cherry S, Webby RJ, Webster RG, Kelso A, Barr IG, McCauley JW, Daniels RS, Wang D, Shu Y, Nobusawa E, Itamura S, Tashiro M, Harada Y, Watanabe S, Odagiri T, et al. Influenza gain-of-function experiments: their role in vaccine virus recommendation and pandemic preparedness. Mbio. 5. PMID 25505124 DOI: 10.1128/Mbio.02430-14  1
2014 Perera HK, Vijaykrishna D, Premarathna AG, Jayamaha CJ, Wickramasinghe G, Cheung CL, Yeung MF, Poon LL, Perera AK, Barr IG, Guan Y, Peiris M. Molecular epidemiology of influenza A(H1N1)pdm09 virus among humans and swine, Sri Lanka. Emerging Infectious Diseases. 20: 2080-4. PMID 25417652 DOI: 10.3201/eid2012.140842  1
2014 Hsu JP, Zhao X, Chen MI, Cook AR, Lee V, Lim WY, Tan L, Barr IG, Jiang L, Tan CL, Phoon MC, Cui L, Lin R, Leo YS, Chow VT. Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore. Bmc Infectious Diseases. 14: 414. PMID 25066592 DOI: 10.1186/1471-2334-14-414  1
2014 Donis RO, Davis CT, Foust A, Hossain MJ, Johnson A, Klimov A, Loughlin R, Xu X, Tsai T, Blayer S, Trusheim H, Colegate T, Fox J, ... ... Barr I, et al. Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing. Vaccine. 32: 6583-90. PMID 24975811 DOI: 10.1016/J.Vaccine.2014.06.045  1
2014 Oh DY, Lowther S, McCaw JM, Sullivan SG, Leang SK, Haining J, Arkinstall R, Kelso A, Mcvernon J, Barr IG, Middleton D, Hurt AC. Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact. The Journal of Antimicrobial Chemotherapy. 69: 2458-69. PMID 24840623 DOI: 10.1093/Jac/Dku146  1
2014 Leang SK, Kwok S, Sullivan SG, Maurer-Stroh S, Kelso A, Barr IG, Hurt AC. Peramivir and laninamivir susceptibility of circulating influenza A and B viruses. Influenza and Other Respiratory Viruses. 8: 135-9. PMID 24734292 DOI: 10.1111/Irv.12187  1
2014 Butler J, Hooper KA, Petrie S, Lee R, Maurer-Stroh S, Reh L, Guarnaccia T, Baas C, Xue L, Vitesnik S, Leang SK, McVernon J, Kelso A, Barr IG, McCaw JM, et al. Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses. Plos Pathogens. 10: e1004065. PMID 24699865 DOI: 10.1371/journal.ppat.1004065  1
2014 Barr IG, Russell C, Besselaar TG, Cox NJ, Daniels RS, Donis R, Engelhardt OG, Grohmann G, Itamura S, Kelso A, McCauley J, Odagiri T, Schultz-Cherry S, Shu Y, Smith D, et al. WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013. Vaccine. 32: 4713-25. PMID 24582632 DOI: 10.1016/J.Vaccine.2014.02.014  1
2014 Zhou B, Lin X, Wang W, Halpin RA, Bera J, Stockwell TB, Barr IG, Wentworth DE. Universal influenza B virus genomic amplification facilitates sequencing, diagnostics, and reverse genetics. Journal of Clinical Microbiology. 52: 1330-7. PMID 24501036 DOI: 10.1128/JCM.03265-13  1
2014 Weitz SH, Gong M, Barr I, Weiss S, Guo F. Processing of microRNA primary transcripts requires heme in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America. 111: 1861-6. PMID 24449907 DOI: 10.1073/Pnas.1309915111  1
2014 McVernon J, Laurie K, Faddy H, Irving D, Nolan T, Barr I, Kelso A. Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia. Influenza and Other Respiratory Viruses. 8: 194-200. PMID 24382379 DOI: 10.1111/irv.12225  1
2014 Barr I, Guo F. Primary microRNA processing assay reconstituted using recombinant drosha and DGCR8 Methods in Molecular Biology. 1095: 73-86. PMID 24166303 DOI: 10.1007/978-1-62703-703-7-5  1
2013 Koel BF, Burke DF, Bestebroer TM, van der Vliet S, Zondag GC, Vervaet G, Skepner E, Lewis NS, Spronken MI, Russell CA, Eropkin MY, Hurt AC, Barr IG, de Jong JC, Rimmelzwaan GF, et al. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science (New York, N.Y.). 342: 976-9. PMID 24264991 DOI: 10.1126/science.1244730  1
2013 Chen MI, Cook AR, Lim WY, Lin R, Cui L, Barr IG, Kelso A, Chow VT, Leo YS, Hsu JP, Shaw R, Chew S, Yap JK, Phoon MC, Koh HW, et al. Factors influencing infection by pandemic influenza A(H1N1)pdm09 over three epidemic waves in Singapore. Influenza and Other Respiratory Viruses. 7: 1380-9. PMID 23829633 DOI: 10.1111/irv.12129  1
2013 Rockman S, Brown LE, Barr IG, Gilbertson B, Lowther S, Kachurin A, Kachurina O, Klippel J, Bodle J, Pearse M, Middleton D. Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine. Journal of Virology. 87: 3053-61. PMID 23283953 DOI: 10.1128/JVI.02434-12  1
2013 Leang SK, Deng YM, Shaw R, Caldwell N, Iannello P, Komadina N, Buchy P, Chittaganpitch M, Dwyer DE, Fagan P, Gourinat AC, Hammill F, Horwood PF, Huang QS, Ip PK, ... ... Barr IG, et al. Influenza antiviral resistance in the Asia-Pacific region during 2011. Antiviral Research. 97: 206-10. PMID 23274624 DOI: 10.1016/j.antiviral.2012.12.016  1
2013 Chin R, Earnest-Silviera L, Gordon CL, Olsen K, Barr I, Brown LE, Jackson DC, Torresi J. Impaired dendritic cell maturation in response to pandemic H1N109 influenza virus. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 56: 226-31. PMID 23218952 DOI: 10.1016/j.jcv.2012.11.009  1
2012 Soh SE, Cook AR, Chen MI, Lee VJ, Cutter JL, Chow VT, Tee NW, Lin RT, Lim WY, Barr IG, Lin C, Phoon MC, Ang LW, Sethi SK, Chong CY, et al. Teacher led school-based surveillance can allow accurate tracking of emerging infectious diseases - evidence from serial cross-sectional surveys of febrile respiratory illness during the H1N1 2009 influenza pandemic in Singapore. Bmc Infectious Diseases. 12: 336. PMID 23206689 DOI: 10.1186/1471-2334-12-336  1
2012 Klimov AI, Garten R, Russell C, Barr IG, Besselaar TG, Daniels R, Engelhardt OG, Grohmann G, Itamura S, Kelso A, McCauley J, Odagiri T, Smith D, Tashiro M, Xu X, et al. WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011. Vaccine. 30: 6461-71. PMID 22917957 DOI: 10.1016/J.Vaccine.2012.07.089  1
2012 Senturia R, Laganowsky A, Barr I, Scheidemantle BD, Guo F. Dimerization and heme binding are conserved in amphibian and starfish homologues of the microRNA processing protein DGCR8. Plos One. 7: e39688. PMID 22768307 DOI: 10.1371/journal.pone.0039688  1
2012 Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Leang SK, Lee RT, Iannello P, Gehrig N, Shaw R, Wark P, Caldwell N, Givney RC, Xue L, Maurer-Stroh S, ... ... Barr IG, et al. Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. The Journal of Infectious Diseases. 206: 148-57. PMID 22561367 DOI: 10.1093/infdis/jis337  1
2012 Rockman S, Middleton DJ, Pearse MJ, Barr IG, Lowther S, Brown LE. Control of pandemic (H1N1) 2009 influenza virus infection of ferret lungs by non-adjuvant-containing pandemic and seasonal vaccines. Vaccine. 30: 3618-23. PMID 22464969 DOI: 10.1016/j.vaccine.2012.03.043  1
2012 Meer EJ, Wang DO, Kim S, Barr I, Guo F, Martin KC. Identification of a cis-acting element that localizes mRNA to synapses. Proceedings of the National Academy of Sciences of the United States of America. 109: 4639-44. PMID 22383561 DOI: 10.1073/pnas.1116269109  1
2012 Barr I, Smith AT, Chen Y, Senturia R, Burstyn JN, Guo F. Ferric, not ferrous, heme activates RNA-binding protein DGCR8 for primary microRNA processing. Proceedings of the National Academy of Sciences of the United States of America. 109: 1919-24. PMID 22308374 DOI: 10.1073/Pnas.1114514109  1
2011 Lim WY, Chen CH, Ma Y, Chen MI, Lee VJ, Cook AR, Tan LW, Flores Tabo N, Barr I, Cui L, Lin RT, Leo YS, Chia KS. Risk factors for pandemic (H1N1) 2009 seroconversion among adults, Singapore, 2009. Emerging Infectious Diseases. 17: 1455-62. PMID 21801623 DOI: 10.3201/eid1708.101270  1
2011 Lee VJ, Chen MI, Yap J, Ong J, Lim WY, Lin RT, Barr I, Ong JB, Mak TM, Goh LG, Leo YS, Kelly PM, Cook AR. Comparability of different methods for estimating influenza infection rates over a single epidemic wave. American Journal of Epidemiology. 174: 468-78. PMID 21719743 DOI: 10.1093/aje/kwr113  1
2011 Teo J, Di Pietro P, San Biagio F, Capozzoli M, Deng YM, Barr I, Caldwell N, Ong KL, Sato M, Tan R, Lin R. VereFlu™: an integrated multiplex RT-PCR and microarray assay for rapid detection and identification of human influenza A and B viruses using lab-on-chip technology. Archives of Virology. 156: 1371-8. PMID 21503642 DOI: 10.1007/s00705-011-0999-7  1
2011 Barr I, Smith AT, Senturia R, Chen Y, Scheidemantle BD, Burstyn JN, Guo F. DiGeorge critical region 8 (DGCR8) is a double-cysteine-ligated heme protein. The Journal of Biological Chemistry. 286: 16716-25. PMID 21454614 DOI: 10.1074/Jbc.M110.180844  1
2011 Deng YM, Caldwell N, Hurt A, Shaw T, Kelso A, Chidlow G, Williams S, Smith D, Barr I. A comparison of pyrosequencing and neuraminidase inhibition assays for the detection of oseltamivir-resistant pandemic influenza A(H1N1) 2009 viruses Antiviral Research. 90: 87-91. PMID 21376084 DOI: 10.1016/j.antiviral.2011.02.014  1
2011 Tong SYC, Dakh F, Hurt AC, Deng YM, Freeman K, Fagan PK, Barr IG, Giffard PM. Rapid detection of the H275Y Oseltamivir resistance mutation in influenza A/H1N1 2009 by single base pair RT-PCR and high-resolution melting Plos One. 6. DOI: 10.1371/journal.pone.0021446  1
2010 Chen MI, Lee VJ, Barr I, Lin C, Goh R, Lee C, Singh B, Tan J, Lim WY, Cook AR, Ang B, Chow A, Tan BH, Loh J, Shaw R, et al. Risk factors for pandemic (H1N1) 2009 virus seroconversion among hospital staff, Singapore. Emerging Infectious Diseases. 16: 1554-61. PMID 20875280 DOI: 10.3201/Eid1610.100516  1
2010 Chen MI, Barr IG, Koh GC, Lee VJ, Lee CP, Shaw R, Lin C, Yap J, Cook AR, Tan BH, Loh JP, Barkham T, Chow VT, Lin RT, Leo YS. Serological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralization assays: an observational study. Plos One. 5: e12474. PMID 20814575 DOI: 10.1371/journal.pone.0012474  1
2010 Hurt AC, Nor'e SS, McCaw JM, Fryer HR, Mosse J, McLean AR, Barr IG. Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model. Journal of Virology. 84: 9427-38. PMID 20631138 DOI: 10.1128/JVI.00373-10  1
2010 Lee VJ, Yap J, Tay JK, Barr I, Gao Q, Ho HJ, Tan BH, Kelly PM, Tambyah PA, Kelso A, Chen MI. Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009. Bmc Infectious Diseases. 10: 164. PMID 20537158 DOI: 10.1186/1471-2334-10-164  1
2010 Chen MI, Lee VJ, Lim WY, Barr IG, Lin RT, Koh GC, Yap J, Cui L, Cook AR, Laurie K, Tan LW, Tan BH, Loh J, Shaw R, Durrant C, et al. 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. Jama. 303: 1383-91. PMID 20388894 DOI: 10.1001/jama.2010.404  1
2010 Lam WY, Leung TF, Lee N, Cheung JL, Yeung AC, Ho YI, Chan RC, Fung KS, Barr IG, Hui DS, Sung JJ, Chan PK. Development and comparison of molecular assays for the rapid detection of the pandemic influenza A (H1N1) 2009 virus. Journal of Medical Virology. 82: 675-83. PMID 20166184 DOI: 10.1002/jmv.21725  1
2010 Barr IG, McCauley J, Cox N, Daniels R, Engelhardt OG, Fukuda K, Grohmann G, Hay A, Kelso A, Klimov A, Odagiri T, Smith D, Russell C, Tashiro M, Webby R, et al. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 northern hemisphere season. Vaccine. 28: 1156-67. PMID 20004635 DOI: 10.1016/J.Vaccine.2009.11.043  1
2009 Dashper SG, Ang CS, Veith PD, Mitchell HL, Lo AW, Seers CA, Walsh KA, Slakeski N, Chen D, Lissel JP, Butler CA, O'Brien-Simpson NM, Barr IG, Reynolds EC. Response of Porphyromonas gingivalis to heme limitation in continuous culture. Journal of Bacteriology. 191: 1044-55. PMID 19028886 DOI: 10.1128/JB.01270-08  1
2008 Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine. 26: D31-4. PMID 19230156 DOI: 10.1016/J.Vaccine.2008.07.078  1
2008 Wang Q, Barr I, Guo F, Lee C. Evidence of a novel RNA secondary structure in the coding region of HIV-1 pol gene. Rna (New York, N.Y.). 14: 2478-88. PMID 18974280 DOI: 10.1261/Rna.1252608  1
2008 Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, et al. The global circulation of seasonal influenza A (H3N2) viruses. Science (New York, N.Y.). 320: 340-6. PMID 18420927 DOI: 10.1126/Science.1154137  1
2007 Hurt AC, Alexander R, Hibbert J, Deed N, Barr IG. Performance of six influenza rapid tests in detecting human influenza in clinical specimens Journal of Clinical Virology. 39: 132-135. PMID 17452000 DOI: 10.1016/j.jcv.2007.03.002  1
2006 Frazer LT, O'Brien-Simpson NM, Slakeski N, Walsh KA, Veith PD, Chen CG, Barr IG, Reynolds EC. Vaccination with recombinant adhesins from the RgpA-Kgp proteinase-adhesin complex protects against Porphyromonas gingivalis infection. Vaccine. 24: 6542-54. PMID 16839648 DOI: 10.1016/j.vaccine.2006.06.013  1
2001 Ross BC, Czajkowski L, Hocking D, Margetts M, Webb E, Rothel L, Patterson M, Agius C, Camuglia S, Reynolds E, Littlejohn T, Gaeta B, Ng A, Kuczek ES, Mattick JS, ... ... Barr IG, et al. Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. Vaccine. 19: 4135-42. PMID 11457538 DOI: 10.1016/S0264-410X(01)00173-6  1
Show low-probability matches.